bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2023,
Volume and Issue:
unknown
Published: Sept. 29, 2023
Expansion
of
a
hexanucleotide
repeat
in
noncoding
region
the
C9ORF72
gene
is
responsible
for
significant
fraction
Amyotrophic
Lateral
Sclerosis
(ALS)
and
Frontotemporal
Dementia
(FTD)
cases,
but
mechanisms
linking
mutant
products
to
neuronal
toxicity
remain
debatable.
Pathogenesis
was
proposed
involve
production
toxic
RNA
species
and/or
accumulation
dipeptide
repeats
(DPRs)
distinguishing
between
these
has
been
challenging.
In
this
study,
we
first
use
complementary
model
systems
analyzing
pathogenesis
adult-onset
neurodegenerative
diseases
characterize
pathogenicity
DPRs
produced
by
Repeat
Associated
Non-ATG
translation
specific
cellular
compartments:
isolated
axoplasm
giant
synapse
from
squid.
Results
showed
selective
axonal
presynaptic
GP-DPRs,
independent
associated
RNA.
These
effects
involved
MAPK
signaling
pathway
that
affects
fast
transport
synaptic
function,
pathogenic
mechanism
shared
with
other
proteins
familial
ALS,
like
SOD1
FUS.
primary
cultured
neurons,
GP
not
promote
"dying-back"
axonopathy
seen
ALS.
Interestingly,
GR-
PR-DPRs,
which
had
no
effect
on
or
transmission,
were
found
disrupt
nuclear
membrane,
promoting
"dying-forward"
neuropathy.
All
C9-DPR-mediated
observed
studies
are
whether
corresponding
mRNAs
contained
alternative
codons.
Finally,
human
tissues
confirmed
close
association
active
P38
degenerating
motor
neurons
as
well
GR-associated
damage
cortex.
Collectively,
our
establish
compartment-specific
C9-DPRs
degeneration,
suggesting
two
may
contribute
disease
heterogeneity
synergize
progression
patients
ALS
FTD
symptoms.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Feb. 4, 2024
SUMMARY
ALS
and
FTD
are
complex
neurodegenerative
disorders
that
primarily
affects
motor
neurons
in
the
brain
spinal
cord,
cortical
frontal
lobe.
Although
pathogenesis
of
ALS/FTD
is
unclear,
recent
research
spotlights
nucleocytoplasmic
transport
impairment,
DNA
damage,
nuclear
abnormalities
as
drivers
neuronal
death.
In
this
study,
we
show
loss
envelope
(NE)
integrity
a
key
pathology
associated
with
pore
(NPC)
injury
C9ORF72
mutant
neurons.
Importantly,
mechanical
stresses
generated
by
cytoskeletal
forces
on
NE
can
lead
to
NPC
injury,
integrity,
accumulation
damage.
demonstrate
restoring
tensional
homeostasis,
disconnecting
nucleus
from
cytoskeleton,
rescue
reduce
damage
cells.
Together,
our
data
suggest
modulation
homeostasis
repair
may
represent
novel
promising
therapeutic
target
for
ALS/FTD.
Brain,
Journal Year:
2024,
Volume and Issue:
147(7), P. 2289 - 2307
Published: March 6, 2024
Abstract
Frontotemporal
dementia
and
amyotrophic
lateral
sclerosis
are
common
forms
of
neurodegenerative
disease
that
share
overlapping
genetics
pathologies.
Crucially,
no
significantly
disease-modifying
treatments
available
for
either
disease.
Identifying
the
earliest
changes
initiate
neuronal
dysfunction
is
important
designing
effective
intervention
therapeutics.
The
genes
mutated
in
genetic
frontotemporal
have
diverse
cellular
functions,
multiple
mechanisms
been
proposed
both.
Identification
a
convergent
mechanism
would
focus
research
targetable
pathway,
which
could
potentially
effectively
treat
all
(both
familial
sporadic).
Synaptopathies
diseases
resulting
from
physiological
synapses,
define
stages
diseases,
with
synapse
loss
key
feature
dementia.
At
presynapse,
process
synaptic
vesicle
recruitment,
fusion
recycling
necessary
activity-dependent
neurotransmitter
release.
unique
distal
location
presynaptic
terminal
means
tight
spatio-temporal
control
homeostasis
dependent
on
efficient
local
protein
translation
degradation.
Recently,
numerous
publications
shown
mutations
associated
present
synaptopathy
characterized
by
dysfunction.
This
review
will
describe
complex
signalling
membrane
trafficking
events
occur
at
presynapse
to
facilitate
neurotransmission
summarize
recent
linking
dementia/amyotrophic
function.
evidence
indicates
an
early
event
illustrates
need
further
this
area,
identify
potential
therapeutic
targets
ability
impact
pathomechanism.
Molecular Neurodegeneration,
Journal Year:
2023,
Volume and Issue:
18(1)
Published: Aug. 7, 2023
Abstract
The
AAA
+
ATPase
valosin
containing
protein
(VCP)
is
essential
for
cell
and
organ
homeostasis,
especially
in
cells
of
the
nervous
system.
As
part
a
large
network,
VCP
collaborates
with
many
cofactors
to
ensure
proteostasis
under
normal,
stress,
disease
conditions.
A
number
mutations
have
revealed
importance
human
health.
In
particular,
facilitates
dismantling
aggregates
removal
dysfunctional
organelles.
These
are
critical
events
prevent
malfunction
brain
other
parts
line
this
idea,
mutants
linked
onset
progression
neurodegeneration
diseases.
intricate
molecular
mechanisms
that
connect
distinct
pathologies
continue
be
uncovered.
Emerging
evidence
supports
model
controls
cellular
functions
on
multiple
levels
type
specific
fashion.
Accordingly,
derail
homeostasis
through
several
can
instigate
disease.
Our
review
focuses
association
between
neurodegeneration.
We
discuss
latest
insights
field,
emphasize
open
questions,
speculate
potential
as
drug
target
some
most
devastating
forms
Journal of Integrative Neuroscience,
Journal Year:
2023,
Volume and Issue:
22(3)
Published: May 6, 2023
As
a
large
and
heterogeneous
group
of
disorders,
neurodegenerative
diseases
are
characterized
by
the
progressive
loss
structure
or
function
in
neurons,
finally
leading
to
neuronal
death.
Neurodegenerative
cause
serious
threat
patient’s
quality
life
most
common
Alzheimer’s
disease
Parkinson’s
disease.
Currently,
little
is
known
detailed
etiology
these
disorders;
as
such,
there
no
effective
treatments
available.
Furthermore,
lack
targeted,
effective,
resolvable
therapy
for
diseases,
represents
an
expanding
research
field
discovery
new
therapeutic
strategies.
Investigations
potential
pathogenesis
will
become
basis
preventing
occurrence
development
finding
therapies.
Existing
theories
mechanisms,
such
genetic
environmental
factors,
abnormal
protein
accumulation,
oxidative
stress,
intricately
associated
with
each
other.
However,
molecular
theory
that
can
entirely
explain
pathological
processes
underlying
diseases.
Due
experimental
technology
support
multidisciplinary
integration,
it
has
been
possible
perform
more
in-depth
on
targets
have
many
exciting
discoveries
terms
original
mechanisms.
With
this
review,
we
intend
review
existing
literature
provide
insights
into
mechanisms
Frontiers in Neuroscience,
Journal Year:
2023,
Volume and Issue:
17
Published: Aug. 10, 2023
Amyotrophic
lateral
sclerosis
(ALS)
is
a
progressive
and
fatal
neurodegenerative
disease
that
leads
to
the
massive
loss
of
motor
neurons
in
cerebrum,
brain
stem
spinal
cord.
It
affects
not
only
but
also
other
glial
cells,
resulting
muscle
atrophy,
severe
disability
eventual
death
due
respiratory
failure.
The
pathogenesis
ALS
fully
understood.
Currently,
several
factors
are
considered
be
involved
ALS,
such
as
genetic
factors,
imbalances
protein
homeostasis,
RNA
metabolism
disorders,
mitochondrial
dysfunctions,
glutamate-mediated
excitatory
toxicities
intra-neuronal
material
transport
disorders
neurons.
study
mutations
related
will
link
molecular
cellular
mechanisms
disease,
thus
enhancing
understanding
its
occurrence
progression,
thereby
providing
new
insights
for
ALS.
This
review
summarizes
current
npj Systems Biology and Applications,
Journal Year:
2025,
Volume and Issue:
11(1)
Published: March 17, 2025
A
molecular
systems
architecture
is
presented
for
the
neuromuscular
junction
(NMJ)
in
order
to
provide
a
framework
organizing
complexity
of
biomolecular
interactions
amyotrophic
lateral
sclerosis
(ALS)
using
systematic
literature
review
process.
ALS
fatal
motor
neuron
disease
characterized
by
progressive
degeneration
upper
and
lower
neurons
that
supply
voluntary
muscles.
The
contains
cells
such
as
neurons,
skeletal
muscle
cells,
astrocytes,
microglia,
Schwann
endothelial
which
are
implicated
pathogenesis
ALS.
This
provides
multi-layered
understanding
intra-
inter-cellular
microenvironment,
may
be
utilized
target
identification,
discovery
single
combination
therapeutics,
clinical
strategies
treat
Molecular Neurobiology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 3, 2025
Abstract
Amyotrophic
lateral
sclerosis
(ALS)
is
a
progressive
and
fatal
motor
neuron
disease
characterized
by
the
pathological
loss
of
upper
lower
neurons.
Whereas
most
ALS
cases
are
caused
combination
environmental
factors
genetic
susceptibility,
in
relatively
small
proportion
cases,
disorder
results
from
mutations
genes
that
inherited.
Defects
several
different
cellular
mechanisms
processes
contribute
to
selective
neurons
(MNs)
ALS.
Prominent
among
these
accumulation
aggregates
misfolded
proteins
or
peptides
which
toxic
These
accumulating
stress
ability
endoplasmic
reticulum
(ER)
function
normally,
cause
defects
transport
between
ER
Golgi,
impair
RNA,
proteins,
organelles,
such
as
mitochondria,
within
axons
dendrites,
all
degeneration
MNs.
Although
dysfunction
variety
combines
towards
pathogenesis
ALS,
this
review,
we
focus
on
recent
advances
concerning
involvement
defective
stress,
vesicular
axonal
transport.
Graphical